Her tenure on Bravo’s infamous show about powerful women in the Big Apple may have been short, but this former Real Housewife of New York City, Cindy Barshop, was always business first. And while her business Completely Bare, both spa and products, has mostly been focused on hair removal, one of her latest ventures is all about keeping the vagina healthy.
Opening the VSpot in 2016 on the Upper East Side, it seems natural that Barshop would extend her portfolio into opening a medical spa focused on vaginal health.
“I am kind of a tech-head,” Barshop said. “I noticed there was new tech for incontinence in Europe. It sounded too good to be true, to treat vaginal dryness, incontinence, pain with intercourse…Dr. [Carolyn] DeLucia was one of the first ones to come to the States. We talked, and I got the treatment FemiLift, and I was shocked at how well it worked.”
Barshop was so convinced of that non-surgical vaginal rejuvenation was the next frontier — “It should be the No. 1 treatment out there for women” — that she opened a space in Manhattan, and hired gynecologist Dr. DeLucia as her principal doctor at the practice because they both “knew it was going to change people’s lives.”
Related (Link: NSFW): RealSelf guide to non-surgical vaginal rejuvenation treatments
How the spa works
Dr. DeLucia is leading the selection of treatments they offer. An expert in women’s health, she often travels around the world to discover new treatments.
“I’m very blessed to have encounters with the right people and be included as faculty for the American Aesthetic Association and for the Cellular Medicine Association with Dr. Charles Runels, inventor of the O-Shot,” says Dr. DeLucia. “I’ve traveled to Dubai, Madrid, Monte Carlo, Athens, Jordan, India, to train physicians on these technologies, but the true value of going there and teaching what we know is learning what they know.
“The advances in Europe, where there is no FDA, gives us the opportunity to see the newest tech and ideas a bit before everybody else,” she continues. “I come back and say, ‘Cindy, we gotta do this, we gotta do that.’ ”
Both Barshop and DeLucia have their eyes on the pulse of Europe — and they say as soon as the FDA allows doctors in the U.S. clearance or approval for new technologies, they’re on it. VSpot offers a variety of treatments, from non-surgical vaginal lasers to the O-Shot to PRP. It’s a spa-like list that can address almost any feminine concern, from common issues after childbirth, to improving sex life after menopause. The list of treatments is something that they have tested to ensure that there are great options to treat almost any concern.
“One of the most important things is really how Carolyn [Dr. DeLucia] customizes the treatment with a little bit of a twist,” says Barshop. “She does customize treatment plans for each person.”
“Different tech hits different tissues,” says Dr. DeLucia. “Some offices will only offer radiofrequency devices because that’s all they could afford to buy. The difference is that we have them all, and that gives me the permission to do something different for everyone.”
The hottest new treatment — the Kegel throne
The latest buzzworthy treatment in women’s health? It’s Emsella, or what they’ve dubbed the “Kegel throne,” from manufacturer BTL in Europe. A chair — that’s right, a chair — that you sit in for about 30 minutes to strengthen your pelvic floor and tighten your vagina. It works by using electromagnetic energy to engage your pelvic muscles — you do the equivalent of “11,000 Kegels in a half hour,” says Dr. DeLucia. She says that we’ll soon be hearing a lot more about Emsella in the U.S.
So why do this? Why branch off from a successful hair removal business into a medical aesthetic spa that focuses on vaginal health?
“We are making such a difference in women’s lives right now,” said Barshop. “We want to help them feel better about themselves. The women who come in are confident, healthy, and strong women, they just have something they want to change.”
Editor’s note: The FDA issued a warning about vaginal rejuvenation devices on July 30, 2018. The concern is primarily around misleading marketing of the treatment, but the FDA also cites some reports of patient risks. Overall, it’s important to take this treatment seriously and do your research.